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Abstract: Objective: While the randomized control clinical trial (RCT) has long been viewed as the “gold
standard” for evidence based medicine, researchers and clinicians have also recognized limitations of RCTs
when applied to clinical practice. These limitations arise from the fact that the results of interventions and
procedures of RCTs conducted in controlled institutional settings often differ significantly from results
obtained when the same interventions are applied in clinical practice. Consequently, there are increasing calls
for more research to be carried out in the “real world” setting of clinical practices treating heterogeneous groups
of patients. Studies conducted in clinical practices are referred to as “pragmatic clinical trials” or “pragmatic
studies” and practice based research networks (PBRNs) have been proposed as ideal environments for
conducting pragmatic clinical trials. The purpose of this study is to investigate how well PBRNs have
performed in fulfilling this promise in the US.
Materials and Methods: A study protocol was developed based on PRISMA (Preferred Reporting Items for
Systematic Reviews and Meta-Analyses) guidelines to identify clinical research studies of patient health
outcomes that were conducted in a PBRN setting. The PubMed database was queried for journal articles in
English that contained the search terms “practice based research network” in the abstract or the title of the
article. Existing PubMed filters designed to select only clinical research studies were then applied. Duplicates
were removed and the remaining articles were reviewed by 2 researchers for relevant inclusion and exclusion
criteria. Each article in the final group was reviewed to determine study design, experimental setting, outcome
measures used, main findings, citations count and impact factor of the journal in which the study appeared.
Results: The initial query of the PubMed database returned 571 articles. After applying filters 42 articles
remained. Manual inspection of the full text of the remaining articles yielded a remaining total of 10 studies
that met inclusion criteria. The studies reviewed were a heterogeneous group with a wide range of objectives,
methodologies, patient outcomes and results. Citation counts for all articles were higher than the median
citation count for articles in the journals in which they were published. All articles reviewed were published in
journals with relatively high journal impact factors (JIF) with JIF percentile rankings ranging from the 68th to
the 89th percentiles in their respective journal categories.
Conclusion: Despite the large number of articles returned by the initial search, very few of these turned out to
be clinical studies of patient outcomes. The articles that were not clinical trials covered a wide range of topics
including case studies of the formation of PBRNs, editorials advocating for the creation of PBRNs, calls for
funding of PBRNs, quality improvement studies, provider attitude and opinion surveys, and histories of the
PBRN movement. The studies that were judged to be clinical trials tended to focus on interventions such as
use of mailed reminders or training of family caregivers designed to change patient health related behaviors as
opposed to direct medical interventions or changes in patient treatment protocols. The articles that were judged
to be clinical studies of patient outcomes were of high quality based on citation counts and journal impact
factors.
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INTRODUCTION
Practice based research networks (PBRNs) have been in existence in the U.S. dating back to the 1970s. Initially
developed as collaborations between community based physician practices, their focus encompassed improving
patient outcomes in primary care, epidemiological and prevalence studies, and conducting studies intended to improve
primary care practices such as the assessment of prophylaxis treatment for acute otitis media by community based
pediatricians. In 1979, a group of physicians and researchers proposed the formation of the Ambulatory Sentinel
Practice Project of North America (ASPPN) following a meeting of the North American Primary Care Research Group
(NAPCRG). The ASPPN project later received grant funding from the Rockefeller foundation in 1981 and was
subsequently shortened to Ambulatory Sentinel Practice Network (ASPN) (1).
The formation of new PBRNs continued throughout the 1980s and 1990s. In response, the federal government Agency
for Health Care Research and Quality (AHRQ) began to provide funding to build capacity for practice-based research
and PBRN projects. The Journal of the American Board of Family Medicine published a special issue in 1994 on
practice-based research that contained the results of a survey indicating that there were 28 active networks in North
America. Since then the number of PBRNs increased to 173 in 2016, involving 29,455 practices and 153,736 clinicians
and serving over 86 million patients. Types of networks included 34% mixed specialties; 30% family medicine; 13%
pediatric; 3% each for internal medicine, pharmacy, and dental; and 14% “other”(2).
In a 2011 comprehensive study of PBRNs based on self-reported data collected from registration forms from PBRNs
applying for formal recognition by the AHRQ for inclusion in a the AHRQ national registry of PBRNs, Peterson et
al. reported that “PBRNs are growing in experience and research capacity. With member practices serving
approximately 15% of the US population, PBRNs are adopting more advanced study designs, disseminating and
implementing practice change, and participating in clinical trials. PBRNs provide valuable capacity for investigating
questions of importance to clinical practice, disseminating results, and implementing evidence-based strategies.
PBRNs are well positioned to support the emerging public health role of primary care providers and provide an
essential component of a learning health care system”(3). The study designs used as reported by the PBRNs included:
observational epidemiology; health systems/outcome research; best practice research/modeling; implementation
research; clinical trials; Comparative effectiveness research; methodological research; nonpractice-based community
health interventions, and; pharmaceutical clinical trials.
Ford et al. have identified problems with the majority of published clinical trials in that “…clinical trials do not
adequately inform practice because they were optimized to determine efficacy. Because such trials were performed
with relatively small samples at sites with experienced investigators and highly selected participants, they could be
overestimating benefits and underestimating harm. This led to the belief that more pragmatic trials, designed to show
the real-world effectiveness of the intervention in broad patient groups, were required.”(4) Califf et al. added the
argument that, “the need for high-quality evidence to support decision-making about health and health care by patients,
physicians, care providers, policymakers is well documented. However, serious shortcomings in evidence persist.
Pragmatic clinical trials (PCTs) that use novel techniques and emerging information and communication technologies
to explore important research questions rapidly and at a fraction of the cost incurred by more ‘traditional’ research
methods promise to help close this gap (5).” Heintzman et al. have asserted that a “…particular strength of PBRNs is
their ability to participate in pragmatic trials, which differ from standard clinical trials in that they are performed in
real-world clinical environments and account for variation in routine clinical practice. Pragmatic trials are essential to
testing the translation of experimental findings into heterogeneous settings and to balancing internal and external
validity” (6).
The present study represents an attempt to determine how successful PBRNs have been in conducting pragmatic
clinical trials of interventions that directly impact patient outcomes in the United States. If PBRNs are playing an
important role in “the translation of experimental findings into heterogeneous settings” as suggested above, we
hypothesize that there should be a large number of articles reporting the results of clinical studies conducted in PBRN
settings published in-well regarded medical journals. In addition, these studies should be widely cited in other research
and review articles.
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This study was limited to PBRNs in the US because the funding and operation the US health care delivery system
(and consequently the PBRNs that function as a part of that system) are unique among all other developed countries
in the world (7).

Materials and Methods
Search strategy
The study protocol was developed based on the PRISMA (Preferred Reporting Items for Systematic Reviews and
Meta-Analyses) guidelines. The PRISMA guidelines were developed in 2005 because, “Systematic reviews and metaanalyses are essential to summarize evidence relating to efficacy and safety of health care interventions accurately and
reliably. The clarity and transparency of these reports, however, is not optimal. Poor reporting of systematic reviews
diminishes their value to clinicians, policy makers, and other users.”(6) In response to this situation, an international
group that included experienced authors and methodologists developed the PRISMA statement in 2005, originating
from the QUOROM (Quality Of Reporting Of Meta-analysis) Statement, consisting of a 27 item checklist deemed
essential for transparent reporting of a systematic review and a four- phase flow diagram,(8). The PRISMA guidelines
have since been widely recognized as a preferred guide for the generation of study protocols for systematic reviews
and meta-analysis. See Appendix 1 for a copy of the PRISMA checklist.
The PubMed database was searched to identify medical research studies published in English conducted in a medical
practice-based research setting in the United States that focused on patient health outcomes. The PubMed Advanced
Search Build was use to generate and filter the article queries. The search was conducted on 3/1/2019. No date
parameters were used. We searched for the exact phrase, “practice based research network” in the title or abstract.
Articles were then filtered by the article type using PubMed’s’ article type filters: clinical trial; clinical trial-phase 1;
clinical trial-phase 2; clinical trial-phase 3; clinical trial-phase 4; controlled clinical trial; observational study;
pragmatic clinical trial, and; randomized controlled trial. Titles and abstracts, and, if required, the full text of the article
were reviewed independently by 2 reviewers for inclusion and exclusion criteria. Articles were considered to be
clinical studies and included in the final review if they were judged to meet one of the study type definitions listed
below.

Study Type Definitions
Case Control Study
“A study that compares patients who have a disease or outcome of interest (cases) with patients who do not have the
disease or outcome (controls), and looks back retrospectively to compare how frequently the exposure to a risk factor
is present in each group to determine the relationship between the risk factor and the disease
Case control studies are observational because no intervention is attempted and no attempt is made to alter the course
of the disease. The goal is to retrospectively determine the exposure to the risk factor of interest from each of the two
groups of individuals: cases and controls. These studies are designed to estimate odds. Case control studies are also
known as ‘retrospective studies’ and ‘case-referent studies.’” (9)

Randomized Controlled Trial
“A study design that randomly assigns participants into an experimental group or a control group. As the study is
conducted, the only expected difference between the control and experimental groups in a randomized controlled trial
(RCT) is the outcome variable being studied.” (9)

Cohort Study
“A study design where one or more samples (called cohorts) are followed prospectively and subsequent status
evaluations with respect to a disease or outcome are conducted to determine which initial participants exposure
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characteristics (risk factors) are associated with it. As the study is conducted, outcome from participants in each cohort
is measured and relationships with specific characteristics determined.”(9)

Outcome Measures
To be included in the final group for review the study needed to focus on patient health outcomes.

Primary outcome
The primary outcome was objectively measured patient health outcomes (i.e., mortality, morbidity, patient-reported
outcome measures, physiological measures of health or disease, etc.).

Secondary outcomes
Given the anticipated wide variation in settings, participants, and study designs for studies that met inclusion criteria
we also included indirect measures assumed to be related to patient health. These included: process outcomes (i.e.,
measures of patient compliance with medication orders and treatment plans), and; adverse events.

Data Collection and Analysis
A standardized data sheet was prepared for recording the relevant information from each study that qualified for
inclusion. The data recorded included type of study; number of subjects; objectives of the study; study location; data
collected; outcome measures used; outcome measures results; statistical analyses used (if any); study authors’
conclusions; citation count, and: impact factor of journal in which the article was published. See Appendix 2 for a
copy of the data sheet used.
The count of times the article has been cited by other articles and impact factor of the journal in which the article was
published were used as proxies for a measure of the quality of the published article.
The citation count theoretically informs the reader of the author’s or journals impact in that scientific community.
“Impact Factor is not a perfect tool to measure the quality of articles but there is nothing better and it has the advantage
of already being in existence and is, therefore, a good technique for scientific evaluation. Experience has shown that
in each specialty the best journals are those in which it is most difficult to have an article accepted, and these are the
journals that have a high impact factor.
Most of these journals existed long before the impact factor was devised. The use of impact factor as a measure of
quality is widespread because it fits well with the opinion we have in each field of the best journals in our
specialty.”(10) The journal’s impact factor is derived by 2 elements: the numerator, which is the number of citations
in the current year to items published in the previous 2 years, and the denominator, which is the number of substantive
articles and reviews published in the same 2 years.(7). Citation counts are included in the metadata of most articles
contained in the PubMed database. Impact factors are published each year in the Clarivate Analytics Journal Citation
Report. Impact factors for this study were taken from the 2018 report
(https://jcr.clarivate.com/JCRLandingPageAction.action).
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Figure 1: Journal’s Impact Factor
Full articles that met the final inclusion criteria were read by 1 reviewer who extracted relevant information into the
data collection form. These data collection forms were then reviewed by a second reviewer. All disagreements about
the accuracy of a given data element were resolved through discussion until consensus was reached.

Results
The initial search yielded 571 articles containing the phrase “practice based research network” in the title or abstract.
The PubMed article filters were then applied sequentially as follows: clinical trial (filter with the most significant
reduction in articles); clinical trial-phase 1 (no effect); clinical trial-phase 2 (no effect); clinical trial-phase 3 (no
effect); clinical trial-phase 4 (no effect); controlled clinical trial (no effect); observational study (articles increased in
count by 8); pragmatic clinical trial (no effect), and; randomized controlled trial (no effect). After application of the
filters 42 full text articles remained.
Duplicate articles were removed resulting in 38 full text articles to be reviewed for inclusion in the final set. Of these
38, 4 were excluded for non USA setting, 6 were excluded for no patient outcomes, 6 were excluded as QI only studies,
and 12 were excluded for miscellaneous other reasons (see Figure 2). A final number of 10 articles were identified as
clinical studies that and were included in the content summaries and quality evaluation (citation count and journal
impact factor).
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Figure 2: PRIMSA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow diagram
indicating results of identification and screening process for included and excluded studies
The studies reviewed were a heterogeneous group with a wide range of objectives, methodologies, patient outcomes
and results. See table 1 for a summary of the 10 articles that met the inclusion criteria.
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Citation counts for all articles were higher than the median citation count for articles in the journals in which they
were published. All articles reviewed were published in journals with relatively high journal impact factors (JIF) with
JIF percentile rankings ranging from the 68th to the 89th percentiles in their respective journal categories.

Figure 3: Included Journal Summary

CONCLUSION
Despite the large number of articles returned by the initial search, very few of these turned out to be clinical studies
of patient outcomes. The articles that were not clinical trials covered a wide range of topics including case studies of
the formation of PBRNs, editorials advocating for the creation of PBRNs, calls for funding of PBRNs, quality
improvement studies, provider attitude and opinion surveys, and histories of the PBRN movement. The studies that
were judged to be clinical trials tended to focus on interventions such as use of mailed reminders or training of family
caregivers designed to change patient health related behaviors as opposed to direct medical interventions or changes
in patient treatment protocols. The articles were of high quality based on citation counts and journal impact factors.

DISCUSSION
The relatively small number of PBRN based clinical studies reported in the literature that we found in our research
does not support the conclusion that PBRNs are currently “hot beds” of pragmatic clinical trial research in the U.S.
During our search process we reviewed some articles that cited barriers to conducting clinical studies in PBRN
settings. Fernald et al. reported difficulties in recruiting physicians to participate in PBRN pragmatic clinical trials
because participation often requires significant modifications in the practices of individual physicians that they are
unwilling to make (11). Rhyne et al., report that with the recent termination of major sources of funding from the
AHRQ and other government agencies, maintaining the activities of PBRNs has become increasingly more difficult
(2). Mello, et al. describe a number of privacy and legal barriers to conducting research using existing health
information exchange infrastructures (12). Given the similarities between HIEs and PBRNs it is reasonable to assume
that many of the same barriers apply to PBRNs. Lastly, like the HIE movement, the PBRN movement may be losing
momentum due to shrinking grant funding and lack of workable business cases. While performing initial preparatory
research for this study we clicked on a several links to individual PBRNs listed in the AHRQ PBRN registry at
https://pbrn.ahrq.gov/pbrn-registry. We found that a number of the links were broken. Additionally, PBRNs are
typically made up of small independent physician practices and it is likely the case that given the current massive
consolidation occurring in the U.S. health care system (13) that PBRNs are being replaced by vertically integrated
health care systems and consequently pragmatic clinical trials are being conducted in those settings.
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This study contains some limitations. Limiting the study to the U.S. could mean that the finding of low numbers of
PBRN-based pragmatic clinical trials is a function of the idiosyncrasies of the U.S. health care system. This would be a
good area for additional research. Due to time and resource limitations, we did not search for additional articles based
on manual inspection of the reference section of articles that were included in the final group for review. However, prior
to conducting this study we read a number of systematic reviews of various types and determined that secondary reference
searches contribute relatively few new articles to the final selection. Finally, the PRISMA guidelines call for an estimate
of the bias included in each of the articles selected for final inclusion. This was not done due limitations in the skill set
of the author of this paper at the present time.
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APPENDIX 3
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Pearce, K. A., Love, M. M., Shelton, B. J., Schoenberg, N. E., Williamson, M. A., Barron, M. A., & Houlihan,
J. M. (2008). Cardiovascular Risk Education and Social Support (CaRESS): Report of a Randomized
Controlled Trial from the Kentucky Ambulatory Network (KAN). The Journal of the American Board of
Family Medicine, 21(4), 269–281. https://doi.org/10.3122/jabfm.2008.04.080007

2.

Rodriguez, H. P., Glenn, B. A., Olmos, T. T., Krist, A. H., Shimada, S. L., Kessler, R., … Bastani, R. (2014).
Real-World Implementation and Outcomes of Health Behavior and Mental Health Assessment. The Journal
of the American Board of Family Medicine, 27(3), 356–366. https://doi.org/10.3122/jabfm.2014.03.130264

3.

Levy, B. T., Daly, J. M., Xu, Y., & Ely, J. W. (2012). Mailed Fecal Immunochemical Tests Plus Educational
Materials to Improve Colon Cancer Screening Rates in Iowa Research Network (IRENE) Practices. The
Journal
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American
Board
of
Family
Medicine,
25(1),
73–82.
https://doi.org/10.3122/jabfm.2012.01.110055

4.

Ferrer, R. L., Mody-Bailey, P., Jaen, C. R., Gott, S., & Araujo, S. (2009). A Medical Assistant- Based
Program to Promote Healthy Behaviors in Primary Care. The Annals of Family Medicine, 7(6), 504–512.
https://doi.org/10.1370/afm.1059

5.

Mold, J. W., Fox, C., Wisniewski, A., Lipman, P. D., Krauss, M. R., Harris, D. R., … Gonin, R. (2014).
Implementing Asthma Guidelines Using Practice Facilitation and Local Learning Collaboratives: A
Randomized Controlled Trial. The Annals of Family Medicine, 12(3), 233– 240.
https://doi.org/10.1370/afm.1624

6.

Hunt, J. S., Siemienczuk, J., Touchette, D., & Payne, N. (2004). Impact of educational mailing on the blood
pressure of primary care patients with mild hypertension. Journal of General Internal Medicine, 19(9), 925–
930. https://doi.org/10.1111/j.1525-1497.2004.40046.x

7.

Steiber, A. L., León, J. B., Hand, R. K., Murphy, W. J., Fouque, D., Parrott, J. S., … Cuppari, L. (2015).
Using a Web-Based Nutrition Algorithm in Hemodialysis Patients. Journal of Renal Nutrition, 25(1), 6–16.
https://doi.org/10.1053/j.jrn.2014.06.005

8.

Howard-Thompson, A., Farland, M. Z., Byrd, D. C., Airee, A., Thomas, J., Campbell, J., … Suda, K. J.
(2013). Pharmacist-physician collaboration for diabetes care: cardiovascular outcomes. The Annals of
Pharmacotherapy, 47(11), 1471–1477. https://doi.org/10.1177/1060028013504738

9.

Degenhardt, B., Johnson, J., Gross, S., Hagan, C., Lund, G., & Curry, W. (2014). Preliminary Findings on
the Use of Osteopathic Manipulative Treatment: Outcomes During the Formation of the Practice-Based
Research Network, DO-Touch.NET. The Journal of the American Osteopathic Association, 114(03), 154–
170. https://doi.org/10.7556/jaoa.2014.033

10. Ratanawongsa, N., Handley, M. A., Sarkar, U., Quan, J., Pfeifer, K., Soria, C., & Schillinger, D. (2014).
Diabetes Health Information Technology Innovation to Improve Quality of Life for Health Plan Members in
Urban
Safety
Net.
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Ambulatory
Care
Management,
37(2),
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